|
|
|
| Efficacy of Dipyridamole Combined with Gamma Globulin and Aspirin in the Treatment of Kawasaki Disease and its Effects on Immune Function and Coagulation Function of Children Patients |
| WANG Ru, et al |
| Qionghai People' s Hospital, Hainan Qionghai 571400, China |
|
|
|
|
Abstract Objective: To investigate the efficacy of dipyridamole combined with gamma globulin (intravenous immunoglobulin, IVIG) and aspirin in the treatment of Kawasaki disease (KD) and its effects on immune function and coagulation function of children patients. Methods: 150 children patients with KD were selected and divided into control group and observation group according to the random number table method, with 75 cases in each group. Control group was treated with aspirin tablets + IVIG, and observation group was treated with dipyridamole on the basis of the above medications, and they were treated for 6~8 weeks. The relief times of clinical symptoms, and peripheral blood T lymphocyte subsets and coagulation function indexes before and after treatment were observed in the two groups. The coronary artery injury after treatment was counted in the two groups. Results: The relief times of fever, diffuse mucosal hyperemia, trunk erythema, cervical lymph node swelling and conjunctival hyperemia in observation group were significantly shorter than those in control group (P<0.05). After treatment, the percentage of peripheral blood CD4+ T lymphocyte subsets and the ratio of CD4+/CD8+ T lymphocyte subsets in the two groups were significantly lower than those before treatment (P<0.05) while the percentage of CD8+ T lymphocyte subsets was significantly higher than that before treatment (P<0.05). The level of plasma fibrinogen (Fbg) in the two groups was significantly lower than that before treatment (P<0.05), and the changes in observation group were significantly greater than those in control group (P<0.05). After treatment, the degree of coronary artery injury in observation group was significantly less than that in control group (P<0.05), and the total incidence rate of coronary artery injury in observation group was significantly lower than that in control group (13.33% vs 40.00%) (P<0.05). Conclusion:Dipyridamole combined with IVIG and aspirin has exact efficacy in treating KD. It can significantly enhance the immune function, improve the coagulation dysfunction, and reduce the coronary artery injury.
|
|
|
|
|
|
[1] 张依菡,吴蓉洲,胡军勇,等.不同性别川崎病患儿冠状动脉损害风险差异的内在机制[J].中华流行病学杂志,2019,40(12):1634~1638.
[2] 常春霞.不同剂量丙种球蛋白联合阿司匹林治疗小儿川崎病的临床应用价值分析[J].重庆医学,2018,47(1):243~244.
[3] 邹娜.双嘧达莫辅助丙种球蛋白及阿司匹林治疗川崎病对患儿抗血小板聚集因子及疗效影响研究[J].陕西医学杂志,2018,47(1):102~104.
[4] 张清友,简佩君,杜军保.风湿热,心内膜炎及川崎病委员会,美国心脏病学会及美国儿科学会川崎病的诊断,治疗及长期随访指南介绍[J].中华实用儿科临床杂志,2012,27(13):1049~1056.
[5] 包涵,李晓惠.川崎病抗血栓治疗药物相关基因多态性研究进展[J].中国医药导报,2019,16(11):34~37.
[6] 彭昭娴,黄萍,张丽,等.华法林联合阿司匹林治疗川崎病并多发中型及巨大型冠状动脉瘤临床研究[J].中华实用儿科临床杂志,2019,34(21):1623~1626.
[7] 林爱弟,蓝陈福,李司鹏,等.不同治疗方案对川崎病患儿临床疗效及CRP,PCT的影响[J].中国妇幼健康研究,2019,30(8):995~998.
[8] 汪燕,鲁利群,贺静,等.川崎病患儿炎症因子和免疫功能指标检测的临床意义[J].儿科药学杂志,2018,24(1):4~7.
[9] 刘丽莎,李喆倩,韩勍,等.川崎病患儿凝血指标变化及其临床意义研究[J].南京医科大学学报(自然科学版),2019,39(10):1515~1524. |
|
|
|
2021, Vol. 27 
